Baird Medical Investment Holdings Limited - Asset Resilience Ratio
Baird Medical Investment Holdings Limited (BDMD) has an Asset Resilience Ratio of 0.38% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2019–2024)
This chart shows how Baird Medical Investment Holdings Limited's Asset Resilience Ratio has changed over time. See Baird Medical Investment Holdings Limite financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Baird Medical Investment Holdings Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Baird Medical Investment Holdings Limite.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $295.75K | 0.38% |
| Total Liquid Assets | $295.75K | 0.38% |
Asset Resilience Insights
- Limited Liquidity: Baird Medical Investment Holdings Limited maintains only 0.38% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Baird Medical Investment Holdings Limited Industry Peers by Asset Resilience Ratio
Compare Baird Medical Investment Holdings Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Baird Medical Investment Holdings Limited (2019–2024)
The table below shows the annual Asset Resilience Ratio data for Baird Medical Investment Holdings Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.38% | $295.75K | $77.96 Million | +0.17pp |
| 2023-12-31 | 0.21% | $120.48K | $56.71 Million | -0.25pp |
| 2022-12-31 | 0.46% | $197.00K | $42.62 Million | -1.10pp |
| 2021-12-31 | 1.56% | $407.50K | $26.12 Million | +1.18pp |
| 2020-12-31 | 0.38% | $65.11K | $17.02 Million | +0.07pp |
| 2019-12-31 | 0.31% | $36.62K | $11.76 Million | -- |
About Baird Medical Investment Holdings Limited
Baird Medical Investment Holdings Limited, together with its subsidiaries, engages in research, development, manufacturing, and sales of microwave ablation and other medical devices in the People's Republic of China. The company offers microwave ablation apparatus and needles; long microwave ablation needles; and fine microwave ablation needles for the treatment of benign and malignant tumors, in… Read more